Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Share News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.50
Bid: 130.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 5.00 (3.846%)
Open: 132.50
High: 135.00
Low: 132.50
Prev. Close: 132.50
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

Fri, 27th Jan 2023 18:56

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Diaceutics PLC - Belfast-based testing laboratories company - Signs two enterprise-level, multi-disease data engagements with two pharmaceutical companies with a combined value of USD7 million over a two-year period. Says that the agreements are for its subscription data services. Reports that revenue in 2022 increased 44% to GBP20.0 million from GBP13.9 million in 2021. Adds that revenue is materially ahead of market expectations. Expects earnings before interest, tax, depreciation, and amortization to be in line with market expectations, with an with Ebitda margin similar to 2021. Attributes growth to demand from its pharmaceutical and life science customers.

----------

ICG-Longbow Senior Secured UK Property Debt Investments Ltd - Resolves to return 5.50 pence per ordinary share to shareholders, being GBP6.7 million in total based on the current number of ordinary shares in issue.

----------

Ilika PLC - Hampshire, England-based solid-state battery technology provider - Reports that it is leading a 24-month GBP8.2 million Faraday Battery Challenge collaboration programme "to integrate high silicon content electrodes into its Goliath solid-state batteries to enable automotive level performance". Adds that it will receive a GBP2.8 million grant over the 24-month programme.

----------

Mercia Asset Management PLC - Warwickshire, England-based, regionally-focused asset manager - Says that the final payment of GBP2.1million in relation to its acquisition of a venture capital trust fund management business from NVM Private Equity LLP has become payable. Plans to pay through the issue of 6.5 million new deferred consideration shares at 32.45p each. Expects the deferred consideration shares to start trading on AIM on January 31.

----------

Time Out Group PLC - media and hospitality business - Signs a lease deal with Klepierre Real Estate Espana SLU to open market in Barcelona in the first half of 2024. Says that Time Out Market Barcelona will be located in the Maremagnum shopping and leisure destination in the Port Vell, across 56,500 square feet. Says that this opening increases the line-up of new sites to eight markets in development which are set to open between 2023 and 2027. Does not disclose any details about the lease. "Barcelona is globally regarded as one of the top food destinations in the world and is a perfect fit for our brand. We are excited to bring Time Out Market to this fabulous, vibrant city together with our partners Klepierre and Estrella Damm. We now have an incredibly strong line-up of new Markets that will open in the next few years and with interest from landlords and real estate developers stronger than ever, we expect to further accelerate the signing of new Markets in the year ahead," Co-CEO Jay Coldren says.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Proposes a private placing to raise EUR11.0 million through an accelerated book-building directed at institutional and other investors. Adds that the subscription price per placing share is to be determined on the basis of the bids received in the bookbuild in euros. Says the Finland Branch of Carnegie Investment Bank AB is acting as sole bookrunner and lead manager in the placing.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Apr 2023 20:28

DIRECTOR DEALINGS: Energean shareholder sells GBP6.6 million in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
17 Apr 2023 14:16

IN BRIEF: Diaceutics achieves increase in annual revenue and profit

Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP19.5 million for 2022, up 40% from GBP13.9 million in 2021. Pretax profit is GBP564,000, up from GBP462,000, as operating profit increases to GBP575,000 from GBP550,000 a year earlier. Administrative expenses increase to GBP16.3 million from GBP11.9 million. Earnings before interest, tax, depreciation and amortisation amounts to GBP3.6 million, up from GBP2.3 million. Order book stands at GBP16.9 million at year-end, compared to GBP1.8 million a year earlier.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
13 Mar 2023 11:10

Diaceutics shares resume trading after HSBC buys SVB UK

(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.

Read more
2 Nov 2022 16:20

TRADING UPDATES: Alternative Income assets rise; Ironveld signs deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Sep 2022 16:47

EARNINGS SUMMARY: Animalcare profit climbs; Silver Bullet revenue up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
26 Jul 2022 14:43

IN BRIEF: Diaceutics in positive start to 2022 as order book grows

Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP7.5 million for the six months that ended on June 30, up 25% from GBP6.0 million a year earlier. Says more than 75% of revenue generated through the company's DXRX platform, up 60% from 2021. Diaceutics says half-year revenue and order book growth are in line with expectations.

Read more
13 Jun 2022 11:53

Diaceutics wins USD2 million contract with "top five global" drug firm

(Alliance News) - Diaceutics PLC on Monday it will deliver customised data insights to a "top five global" pharmaceutical firm under a new contract.

Read more
13 Jun 2022 10:30

Diaceutics secures $2m multi-year contract with global pharma company

(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceutical company to deliver customised data insights via its DXRX platform.

Read more
7 Jun 2022 21:20

IN BRIEF: Diaceutics enhances platform to improve customer experience

Diaceutics PLC - UK testing laboratories company - Announces "significant enhancements" to its DXRX platform in order to improve user experience. Company says customers will now be able to access three new AI-powered tools to ensure medicines get to patients quicker.

Read more
5 May 2022 15:15

IN BRIEF: Diaceutics wins five-year contract worth over USD1 million

Diaceutics PLC - UK testing laboratories company - Wins five-year contract worth at least USD1 million with an unnamed "top 30 global" pharmaceutical company, in a multi-product subscription for customised data insights via its DXRX platform. Contract expands existing relationship with the company, and sets stage for future opportunities, it says. Says its offering of customised biomarket test results and interpretation was a key draw for the client, with the client's needs in oncology to be served by DXRX Signal.

Read more
5 May 2022 12:58

Diaceutics inks five-year deal with existing pharma partner

(Sharecast News) - Diaceutics announced a five-year, multi-product subscription contract with an unnamed "top 30" global pharma company on Thursday, to deliver customised data insights via its 'DXRX' platform.

Read more
8 Apr 2022 21:08

DIRECTOR DEALINGS: Taseko Mines director buys shares worth USD293,000

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

Read more
22 Mar 2022 16:24

Diaceutics returns to pretax profit in 2021 and ups revenue

(Alliance News) - Diaceutics PLC said on Tuesday it swung to a pretax profit in 2021 and posted an increase in annual revenue.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.